BioBridgeXAll companies

Finch Therapeutics Group, Inc.

Biotechnology company · Boston, Massachusetts, United States · OTC: FNCHQ

Finch Therapeutics Group, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2017. Its shares trade on OTC under the ticker FNCHQ. It has reported private securities offerings to the US SEC, most recently $90 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Finch Therapeutics Group at a glance

Typebiotechnology company
HeadquartersBoston, Massachusetts, United States
Earliest incorporation on record2017
Stock listingOTC: FNCHQ
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1733257

What does Finch Therapeutics Group do?

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $90 million sold (2020).

Frequently asked questions about Finch Therapeutics Group

Where is Finch Therapeutics Group headquartered?

Finch Therapeutics Group, Inc. is headquartered in Boston, Massachusetts, United States.

What does Finch Therapeutics Group do?

Finch Therapeutics Group, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Finch Therapeutics Group a public company?

Yes. Finch Therapeutics Group, Inc. trades on OTC under the ticker FNCHQ.

When was Finch Therapeutics Group founded?

The earliest incorporation on record for Finch Therapeutics Group, Inc. is in 2017, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences